feed,title,long_url,short_url
Benzinga,Plus Therapeutics Gets DSMB Approval To Start Eighth Cohort For Glioblastoma Trial,https://benzinga.com/general/biotech/21/06/21584740/plus-therapeutics-gets-dsmb-approval-to-start-eighth-cohort-for-glioblastoma-trial,https://j.mp/3pXlzmB
Benzinga,"MacroGenics, Zai Lab Ink Over $1.4B Immuno-Oncology Development Deal",https://benzinga.com/general/biotech/21/06/21584650/macrogenics-zai-lab-ink-over-1-4b-immuno-oncology-development-deal,https://j.mp/3vs5mqt
